A number of other analysts have also recently issued reports on the company. William Blair cut ZELTIQ Aesthetics from an outperform rating to a market perform rating in a research report on Monday. Canaccord Genuity cut ZELTIQ Aesthetics from a buy rating to a hold rating in a research report on Monday. Maxim Group cut ZELTIQ Aesthetics from a buy rating to a hold rating in a research report on Monday. Northland Securities reiterated a positive rating on shares of ZELTIQ Aesthetics in a research report on Monday. Finally, Piper Jaffray Companies cut ZELTIQ Aesthetics from an overweight rating to a neutral rating in a research report on Monday. One analyst has rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the company. ZELTIQ Aesthetics currently has a consensus rating of Hold and a consensus price target of $44.60.
Shares of ZELTIQ Aesthetics (NASDAQ:ZLTQ) opened at 55.93 on Tuesday. ZELTIQ Aesthetics has a 12 month low of $18.41 and a 12 month high of $56.18. The stock has a market cap of $2.24 billion, a P/E ratio of 72.17 and a beta of 1.01. The stock’s 50 day moving average is $43.85 and its 200 day moving average is $40.21.
“ZELTIQ Aesthetics, Inc. (ZLTQ) Cut to “Hold” at Aegis” was originally reported by sleekmoney and is the sole property of of sleekmoney. If you are viewing this piece on another website, it was stolen and republished in violation of US & international trademark and copyright legislation. The original version of this piece can be read at http://sleekmoney.com/zeltiq-aesthetics-inc-zltq-cut-to-hold-at-aegis/1660084.html.
In other news, insider Keith J. Sullivan sold 8,000 shares of the company’s stock in a transaction on Monday, December 5th. The stock was sold at an average price of $43.78, for a total transaction of $350,240.00. Following the transaction, the insider now owns 87,198 shares of the company’s stock, valued at $3,817,528.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Carl Lamm sold 21,600 shares of the company’s stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $45.00, for a total value of $972,000.00. Following the transaction, the vice president now directly owns 34,208 shares in the company, valued at approximately $1,539,360. The disclosure for this sale can be found here. Insiders have sold 57,600 shares of company stock worth $2,535,120 in the last ninety days. 15.60% of the stock is currently owned by insiders.
Several institutional investors have recently modified their holdings of the stock. New York State Teachers Retirement System raised its position in shares of ZELTIQ Aesthetics by 0.4% in the second quarter. New York State Teachers Retirement System now owns 47,852 shares of the company’s stock valued at $1,308,000 after buying an additional 200 shares during the period. Riverbridge Partners LLC raised its position in ZELTIQ Aesthetics by 14.2% in the second quarter. Riverbridge Partners LLC now owns 1,166,362 shares of the company’s stock valued at $31,877,000 after buying an additional 144,781 shares during the last quarter. New Jersey Better Educational Savings Trust raised its position in ZELTIQ Aesthetics by 22.2% in the second quarter. New Jersey Better Educational Savings Trust now owns 22,000 shares of the company’s stock valued at $601,000 after buying an additional 4,000 shares during the last quarter. Handelsinvest Investeringsforvaltning raised its position in ZELTIQ Aesthetics by 135.0% in the second quarter. Handelsinvest Investeringsforvaltning now owns 23,500 shares of the company’s stock valued at $642,000 after buying an additional 13,500 shares during the last quarter. Finally, Nationwide Fund Advisors raised its position in ZELTIQ Aesthetics by 12.2% in the second quarter. Nationwide Fund Advisors now owns 23,254 shares of the company’s stock valued at $636,000 after buying an additional 2,527 shares during the last quarter.
ZELTIQ Aesthetics Company Profile
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/zeltiq-aesthetics-inc-zltq-cut-to-hold-at-aegis/1660084.html
Receive News & Ratings for ZELTIQ Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZELTIQ Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.